Stereotactic Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer: Rationale, Feasibility, and Early Experience Using the CyberKnife Radiosurgery Delivery Platform

Olusola Obayomi-Davies, Thomas P Kole, Bridget Oppong, Sonali Rudra, Erini V Makariou, Lloyd D Campbell, Hozaifa M Anjum, Sean P Collins, Keith Unger, Shawna Willey, Eleni Tousimis, Brian T Collins, Olusola Obayomi-Davies, Thomas P Kole, Bridget Oppong, Sonali Rudra, Erini V Makariou, Lloyd D Campbell, Hozaifa M Anjum, Sean P Collins, Keith Unger, Shawna Willey, Eleni Tousimis, Brian T Collins

Abstract

Purpose: The efficacy of accelerated partial breast irradiation (APBI) utilizing brachytherapy or conventional external beam radiation has been studied in early-stage breast cancer treated with breast-conserving surgery. Data regarding stereotactic treatment approaches are emerging. The CyberKnife linear accelerator enables excellent dose conformality to target structures while adjusting for target and patient motion. We report our institutional experience on the technical feasibility and rationale for stereotactic accelerated partial breast irradiation (SAPBI) delivery using the CyberKnife radiosurgery system.

Methods: Ten patients completed CyberKnife SAPBI (CK-SAPBI) in 2013 at Georgetown University Hospital. Four gold fiducials were implanted around the lumpectomy cavity prior to treatment under ultrasound guidance. The synchrony system tracked intrafraction motion of the fiducials. The clinical target volume was defined on contrast enhanced CT scans using surgical clips and post-operative changes. A 5 mm expansion was added to create the planning treatment volume (PTV). A total dose of 30 Gy was delivered to the PTV in five consecutive fractions. Target and critical structure doses were assessed as per the National Surgical Adjuvant Breast and Bowel Project B-39 study.

Results: At least three fiducials were tracked in 100% of cases. The Mean treated PTV was 70 cm(3) and the mean prescription isodose line was 80%. Mean dose to target volumes and constraints are as follows: 100% of the PTV received the prescription dose (PTV30). The volume of the ipsilateral breast receiving 30 Gy (V30) and above 15 Gy (V > 15) was 14 and 31%, respectively. The ipsilateral lung volume receiving 9 Gy (V9) was 3%, and the contralateral lung volume receiving 1.5 Gy (V1.5) was 8%. For left-sided breast cancers, the volume of heart receiving 1.5 Gy (V1.5) was 31%. Maximum skin dose was 36 Gy. At a median follow-up of 1.3 years, all patients have experienced excellent/good breast cosmesis outcomes, and no breast events have been recorded.

Conclusion: CyberKnife stereotactic accelerated partial breast irradiation is an appealing technique for partial breast irradiation offering improvements over existing APBI techniques. Our early findings indicate that CK-SAPBI delivered in five daily fractions is feasible, well tolerated, and is a reliable platform for delivering APBI.

Keywords: APBI; CyberKnife breast; breast SBRT; breast cancer; breast radiosurgery; partial breast irradiation; stereotactic radiosurgery.

Figures

Figure 1
Figure 1
Axial, sagittal, and coronal views of the treatment planning CT scan demonstrating the PTV (purple) and normal breast (pink), isodose lines shown as follows: 100% of the prescription dose, red line; 50% of the prescription dose, green line; arrow points to gold fiducial marker.
Figure 2
Figure 2
Cumulative dose volume histogram (DVH) for the target PTV and normal tissues. This plan was normalized to deliver 30 Gy to the PTV. Unlabeled structures: left lung; purple. Right lung; yellow. Right breast; light blue.
Figure 3
Figure 3
Frontal view of bilateral breasts showing excellent breast cosmesis 18 months following CyberKnife SAPBI. SAPBI, Stereotactic accelerated partial breast irradiation.

References

    1. NIH consensus conference. Treatment of early-stage breast cancer. JAMA (1991) 265:391–5.10.1001/jama.1991.03460030097037
    1. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med (2002) 347:1233–41.10.1056/NEJMoa022152
    1. van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst (2000) 92:1143–50.10.1093/jnci/92.14.1143
    1. Blichert-Toft M, Rose C, Andersen JA, Overgaard M, Axelsson CK, Andersen KW, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr (1992) (11):19–25.
    1. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med (2002) 347:1227–32.10.1056/NEJMoa020989
    1. EBCTCG. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. Early Breast Cancer Trialists’ Collaborative Group. N Engl J Med (1995) 333:1444–55.
    1. Morrow M, White J, Moughan J, Owen J, Pajack T, Sylvester J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol (2001) 19(8):2254–62.
    1. Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med (1992) 326:1102–7.10.1056/NEJM199204233261702
    1. Legorreta AP, Liu X, Parker RG. Examining the use of breast-conserving treatment for women with breast cancer in a managed care environment. Am J Clin Oncol (2000) 23:438–41.10.1097/00000421-200010000-00002
    1. Arthur DW, Vicini FA. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol (2005) 23:1726–35.10.1200/JCO.2005.09.045
    1. Swanson TA, Vicini FA. Overview of accelerated partial breast irradiation. Curr Oncol Rep (2008) 10:54–60.10.1007/s11912-008-0009-8
    1. Belkacemi Y, Chauvet MP, Giard S, Villette S, Lacornerie T, Bonodeau F, et al. Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study. Radiother Oncol (2009) 90:23–9.10.1016/j.radonc.2008.06.004
    1. Vicini FA, Keisch M, Shah C, Goyal S, Khan AJ, Beitsch PD, et al. Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy. Int J Radiat Oncol Biol Phys (2012) 83:512–8.10.1016/j.ijrobp.2011.07.011
    1. Huang YJ, Blough M. Dosimetric effects of air pocket sizes in MammoSite treatment as accelerated partial breast irradiation for early breast cancer. J Appl Clin Med Phys (2009) 11(1):2932.
    1. Yue NJ, Goyal S, Kim LH, Khan A, Haffty BG. Patterns of intrafractional motion and uncertainties of treatment setup reference systems in accelerated partial breast irradiation for right- and left-sided breast cancer. Pract Radiat Oncol (2014) 4:6–12.10.1016/j.prro.2012.12.003
    1. Yue NJ, Goyal S, Zhou J, Khan AJ, Haffty BG. Intrafractional target motions and uncertainties of treatment setup reference systems in accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys (2011) 79:1549–56.10.1016/j.ijrobp.2010.05.034
    1. Jagsi R, Ben David MA, Moran JM, Marsh RB, Griffith KA, Hayman JA, et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys (2010) 76:71–8.10.1016/j.ijrobp.2009.01.041
    1. Vermeulen S, Cotrutz C, Morris A, Meier R, Buchanan C, Dawson P, et al. Accelerated partial breast irradiation: using the CyberKnife as the radiation delivery platform in the treatment of early breast cancer. Front Oncol (2011) 1:43.10.3389/fonc.2011.00043
    1. Vermeulen SS, Haas JA. CyberKnife stereotactic body radiotherapy and CyberKnife accelerated partial breast irradiation for the treatment of early breast cancer. Transl Cancer Res (2014) 3(4):295–302.10.3978/j.issn.2218-676X.2014.07.06
    1. Xu Q, Chen Y, Grimm J, Fan J, An L, Xue J, et al. Dosimetric investigation of accelerated partial breast irradiation (APBI) using CyberKnife. Med Phys (2012) 39:6621–8.10.1118/1.4757616
    1. Heinzerling JH, Ding C, Ramirez E, Chang K, Anderson JF, Edwards CM, et al. Comparative dose-volume analysis for CyberKnife and 3D conformal partial breast irradiation treatment of early stage breast cancer. Int J Radiat Oncol Biol Phys (2010) 78:S825–6.10.1016/j.ijrobp.2010.07.1911
    1. Fan J, Hayes S, Freedman G, Anderson P, Li J, Wang L, et al. Planning the breast boost: dosimetric comparison of CyberKnife, photon mini tangents, IMRT, and electron techniques. Int J Radiat Oncol Biol Phys (2014) 78:S788–9.10.1016/j.ijrobp.2010.07.1826
    1. Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys (2009) 74:987–1001.10.1016/j.ijrobp.2009.02.031
    1. Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson J, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol (2006) 7:467–71.10.1016/S1470-2045(06)70699-4
    1. Formenti SC. External-beam partial-breast irradiation. Semin Radiat Oncol (2005) 15:92–9.10.1016/j.semradonc.2004.10.008
    1. Livi L, Meattini I, Marrazzo L, Simontacchi G, Pallotta S, Saieva C, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer (2015).10.1016/j.ejca.2014.12.013
    1. Lewin AA, Derhagopian R, Saigal K, Panoff JE, Abitbol A, Wieczorek DJ, et al. Accelerated partial breast irradiation is safe and effective using intensity-modulated radiation therapy in selected early-stage breast cancer. Int J Radiat Oncol Biol Phys (2012) 82:2104–10.10.1016/j.ijrobp.2011.02.024
    1. Smith LA, Kuske RR, Cross MJ. Improved targeting of the lumpectomy cavity using a spiral 3-D marker. Int J Radiat Oncol (2014) 90:S276.10.1016/j.ijrobp.2014.05.944

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa